Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Intravenous Hyoscine Butylbromide Injection on the Course and Duration of First Stage of Labour in Primigavidae

NCT02824679 is registered in ClinicalTrials.gov with Ahmed M Maged, MD as lead sponsor.

NCT NCT02824679
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02824679 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Intravenous Hyoscine Butylbromide Injection on the Course and Duration of First Stage of Labour in Primigavidae
Lead sponsor
Ahmed M Maged, MD
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2015
Completion date
March 31, 2017
Enrollment
200 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

vaginal delivery